543 related articles for article (PubMed ID: 29908451)
1. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
Ran X; Gestwicki JE
Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
[TBL] [Abstract][Full Text] [Related]
2. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
3. Improving small molecule virtual screening strategies for the next generation of therapeutics.
Wingert BM; Camacho CJ
Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
Moon H; Lim HS
Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
[TBL] [Abstract][Full Text] [Related]
6. Rational modulator design by exploitation of protein-protein complex structures.
Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of protein-protein interaction complexes through small molecules.
Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
Arkin MR; Tang Y; Wells JA
Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
[TBL] [Abstract][Full Text] [Related]
9. Developing drugs for the 'undruggable'.
Sawyer A
Biotechniques; 2020 Oct; 69(4):239-241. PubMed ID: 33054382
[TBL] [Abstract][Full Text] [Related]
10. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
[TBL] [Abstract][Full Text] [Related]
11. Benchmark Study Based on 2P2I
Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
[TBL] [Abstract][Full Text] [Related]
12. Protein-protein interactions as drug targets.
Skwarczynska M; Ottmann C
Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein-protein interactions and fragment-based drug discovery.
Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
Bier D; Thiel P; Briels J; Ottmann C
Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
[TBL] [Abstract][Full Text] [Related]
15. In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
Kuenemann MA; Sperandio O; Labbé CM; Lagorce D; Miteva MA; Villoutreix BO
Prog Biophys Mol Biol; 2015 Oct; 119(1):20-32. PubMed ID: 25748546
[TBL] [Abstract][Full Text] [Related]
16. Motif mediated protein-protein interactions as drug targets.
Corbi-Verge C; Kim PM
Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Ras-SOS Interactions.
Lu S; Jang H; Zhang J; Nussinov R
ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
[TBL] [Abstract][Full Text] [Related]
18. Modulating protein-protein interactions: the potential of peptides.
Nevola L; Giralt E
Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
[TBL] [Abstract][Full Text] [Related]
19. MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI).
Bellón-Echeverría I; Carralot JP; Del Rosario AA; Kueng S; Mauser H; Schmid G; Thoma R; Berger I
Sci Rep; 2018 Mar; 8(1):5083. PubMed ID: 29572554
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interactions: network analysis and applications in drug discovery.
Bultinck J; Lievens S; Tavernier J
Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
